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Background: While primary immunodeficiencies (PID has been recognized in the west for decades, recognition has
been delayed in the third world. This study attempts to detail the spectrum of PID, the therapy provided, and
constraints in the diagnosis and treatment in a middle income country such as Sri Lanka.
Methods: Nine hundred and forty two patients with recurrent infections and features suggestive of immune
deficiency, referred from the entire country in a 4 year period, to the sole immunology unit in Sri Lanka were
included. The following tests were performed. Full blood counts, serum Immunoglobulin and complement C3 and
C4 levels, functional antibody levels, enumeration of lymphocyte subsets, in vitro and in vivo T cell functional
assays,, nitroblue tetrazolium assay to diagnose chronic granulomatous disease, hair shaft assay to diagnose Griscelli
syndrome. Sequencing of the common gamma chain to identify x linked severe combined immune deficiency, and
X linked agammaglobulinemia was confirmed by assaying for Btk mutations by single sequence conformation
polymorphism. HIV/AIDS was excluded in all patients.
Results: Seventy three patients were diagnosed with a primary immune deficiency. The majority (60.27%) had
antibody deficiency. Common variable immune deficiency was the commonest (28.76%), followed by X linked
agammaglobulinemia (XLA) (20.54%). Five patients had possible hyper IgM syndrome.
Ten patients had severe combined immune deficiency (SCID), including 2 with x linked SCID, in addition to
DiGeorge syndrome (2), ataxia telangiectasia (6), autosomal dominant hyper IgE syndrome (2), chronic
granulomatous disease (4), leucocyte adhesion deficiency type 1 (2) and Griscelli syndrome (3).
Patients with autoinflammatory, innate immune and complement defects could not be identified due to lack of
facilities.
Conclusions: Antibody deficiency is the commonest PID, as in the west.IgA deficiency is rare. Autoinflammatory
diseases, innate immune and complement deficiencies could not be identified due to lack of diagnostic facilities.
Lack of awareness of PID among adult physicians result in delay in treatment of adult patients. While treatment of
antibody deficiencies provided in state hospitals has extended life expectancy, there is no treatment available for
severe T cell defects.
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Birth - < 1 year 362 (38.4)
1 - < 5 years 359 (38.15)
5 - < 12 years 49 (5.2)
12
- < 18 years
41 (4.35)
18
- < 30 years
49 (5.2)





≥ 2 severe infections (pneumonia, sepsis, meningitis,
osteomyelitis)
393 (42.7)
Atypical presentation of infection 6 (0.6)
Unusually severe course, or impaired response to
treatment
230 (24.4)
Unusual or opportunistic agent 10 (1.0)
Recurrent infections with same type of pathogen 60 (6.3)
Abscesses of internal organs, or recurrent subcutaneous
abscesses
115 (12.2)
FTT with prolonged/recurrent diarrhoea 24 (2.5)
Generalized long lasting warts or molluscum
contagiosum
5 (0.5)
Extensive prolonged candidiasis 16 (1.7)
Delayed separation (> 4 weeks) of umbilical cord 2 (0.2)
Delayed shedding of primary teeth 2 (0.2)
F/H of infant deaths, ID, consanguinity 16 (1.7)




Dysmorphic features, especially facial abnormalities,
microcephaly
0
Partial albinism, abnormal hair, severe eczema 3 (0.3)
Telangiectasia, ataxia 10 (1.0)
Gingivitis, oral ulcers/aphthae 0
Absence of immunological tissue 0
Organomegaly 0
Digital clubbing 0
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Primary Immunodeficiencies (PID) are monogenic diseases,
and around 150 such diseases have been identified [1].
Many are yet to be identified. A prevalence of 1: 2000 is
reported in the US, even though this may be an under
estimate [2]. The figures may differ in other countries, for
example Brazil etc. Patients with PID present with recur-
rent infections, but may also have autoimmune diseases,
allergy and malignancy [3].
The International Union of Immunological societies
(IUIS) have classified PID under 8 groups, including
humoral, combined, phagocytic, innate immune and com-
plement defects [4]. In the west, PID has been diagnosed
for more than half a century, whereas in the third world,
recognition of PID is only a few decades old. Diagnostic
and research facilities are few, and therapy is delayed or
not available. Delay in the diagnosis of x linked agamma-
globulinemia till 10 years of age, for example, raises the
risk of chronic lung disease to 40% [5].
Sri Lanka is a recent middle income country (per
capita GDP US $ 2000). It has very few trained immu-
nologists, and only one dedicated Immunology unit, at
the Medical Research Institute, Colombo. Patients with
recurrent infections and suspected immunodeficiency
are referred from the entire country to this unit. The pa-
tients are diagnosed and referred back with treatment
recommendations.
This study attempts to detail the spectrum of PID
identified in a 4 year period from 2008 to June 2012,
the therapy provided, and constraints in the diagnosis
and treatment in a middle income country such as Sri
Lanka.
Material and methods
Nine hundred and forty two patients with recurrent infec-
tions and features suggestive of an underlying immune
deficiency [6] (Table 1), referred to the Department of Im-
munology, Medical Research Institute Colombo, Sri Lanka
were investigated for underlying primary immunodefi-
ciency (PID). These patients were referred to the depart-
ment, from all regions in Sri Lanka as it is the only
dedicated Immunology unit in the country. A total of
10 ml of blood was taken for investigations and the fol-
lowing tests were done; the complete blood count, flow-
cytometry (to quantify T lymphocytes and subsets (CD 3,
CD 4 and CD 8), B lymphocytes (CD 19), and Natural
Killer cells (CD 16/56)(Epics XL, Beckmann Coulter [7],
the monoclonal antibodies were from Becton Dickinson,
BD), serum immunoglobulin (IgG, IgA, IgM) levels by
radial immune diffusion (RID) [8],, serum IgE by ELISA
(Roche), serum Complement C3 and C4 (RID) [9], and
isohemagglutinin levels. T lymphocyte proliferation was
performed, using the mitogen concanavalin A [10]. A
Mantoux test, using purified protein derivative (PPDRT 23) 2TU 0.1 ml given intra dermally, with the diameter
of the induration read at 72 hours, was performed as
an in vivo test of T lymphocyte function. An induration
diameter >0 mm was read as a positive delayed type
hypersensitivity reaction [11]. The nitro blue tetrazolium
assay (NBT) was performed on freshly collected blood
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(Btk)were identified by single sequence conformation
polymorphism (SSCP) [13]. HIV/AIDS was excluded in all
patients using Genscreen™ ULTRA HIV Ag-Ab ELISA to
detect the P24 antigen and antibody to HIV 1 and 2.
The patients were immunized with the typhoid Vi vac-
cine (Serum Institute, India), and a further blood sample
taken 4 weeks later, and the 2 samples were tested for
seroconversion using a typhoid Vi ELISA kit (Binding
Site. UK) [14].
The specific PID was identified by the clinical features
and results of the investigations performed [14]. Griscelli
syndrome was diagnosed by examining the hair shaft for
clumping of melanin pigment [15], while leucocyte
adhesion deficiency was diagnosed by flowcytometry: the
granulocytes were evaluated for the presence of CD 18
(BD) [16].
XLA was diagnosed in male patients with agamma-
globulinemia, absent B cells and a genetic diagnosis using
SSCP [13].
CVID was diagnosed in patients according to guidelines
of the European Society of Immunodeficiencies (ESID)
and the Pan American Group for Immunodeficiencies
[17]. Patients over 2 years of age, with low (< 2 SD) IgG,
and a low IgA or IgM, and no seroconversion following
immunization with the typhoid Vi vaccine or absent
isohemagglutinins and after exclusion of other causes
of hypogammaglobulinemia were considered as having
CVID. Conditions such as XLA, Good’s syndrome (no
thymoma by HRCT), proteinuria, protein losing entero-
pathy, use of drugs such as Rituximab, anti convulsants
etc. were excluded in these patients [18].
Severe combined immune deficiency (SCID) was diag-
nosed by flowcytometry [19], ataxia telangiectasia (AT) in
children by the presence of ataxia, ocular cutaneous
telangiectasia and elevated alpha feto protein levels [20]
and Di George syndrome by the presence of neonatal
hypocalcaemia, conotruncal cardiac defects, typical facies
and absent thymus [21]. Autosomal dominant hyper IgE
syndrome [22] was diagnosed using the National Institutes
of Health (NIH) scoring system, with scores of over 40
suggestive of the diagnosis [23]. Chronic granulomatous
disease was confirmed by a positive NBT assay [12].
Pneumocystis jiroveci was diagnosed from respira-
tory secretions and broncho alveolar lavage using the
Grocott-Gomori methenamine silver (GMS) stain [24]
by a trained mycologist. Candida guillermondi was cul-
tured from blood [25].
The study was partly sponsored by the World Health
Organization (WHO), as part of study on polio excretion
in patients with PID. Ethics approval was granted by the
Medical Research Institute, Colombo, Sri Lanka. Written,
informed consent was obtained from the patients or
parents in the case of children less than 18 years.Results
Seventy three patients were diagnosed with a primary im-
mune deficiency (Table 2). Fifty three (72.6%) were ≤ 12
years, 12 (16.4%) ≥18 years and 8 (10.9) ≥ 30 years. The
male to female ratio was 1.3: 1. Seven of the 12 patients
aged ≥ 18 years, and 5 of 8 aged ≥ 30 years were female.
One patient with x linked SCID was diagnosed in utero
(20 weeks of pregnancy), and diagnosis confirmed at birth.
The majority (60.27%) had antibody deficiency. Common
variable immune deficiency was the commonest clinically
significant PID (28.76%), followed by X linked agam-
maglobulinemia (XLA) (20.54%). There were 3 sets of
siblings among patients with XLA. Of the 5 patients with
hyper IgM syndrome, 3 patients, all male, developed
symptoms before the age of 2 years, and had opportunistic
infections (2 with P. jiroveci pneumonia and one who had
C. guillermondi cultured in the blood on two occasions).
All 3 probably had deficiencies of either CD 154 (CD
40 L), or CD 40. One patient was subsequently identified
as having CD 40 deficiency in the US, and successfully
underwent stem cell transplantation [26]. One other pa-
tient had lymphadenopathy and giant germinal centers,
indicating a possible activated cytidine deaminase defi-
ciency [27]. One patient had partial IgA deficiency, but
functional antibody levels were not available.
Ten patients had severe combined immune deficiency
(SCID), including one patient with Omenn syndrome
with features of erythroderma, alopecia, hepatospleno-
megaly, lymphadenopathy and eosinophilia [19]. Of the
other 9 patients with SCID, 5 were T-B + (2 males), and
4, T-B-. The 2 males with T-B + SCID were diagnosed as
having x linked SCID. Sequencing of the common γ
chain of the IL 2 receptor revealed mutations. One of
these patients, with a family history of 15 male infant
deaths spanning 3 generations, underwent stem cell
transplantation in India, and is 3 years old at the time of
writing. Except for two patients with X linked SCID, all
others succumbed during infancy.
The patients with DiGeorge syndrome had symptoms of
hypocalcaemia, cardiac defects (one patient) and typical
facies (Table 3). The immune system however, was not
affected. Chromosomal studies could not be done. Two
patients were diagnosed with autosomal dominant hyper
IgE syndrome, both with National Institutes of Health
scores > 40, suggestive of the diagnosis (Table 3). Ataxia
telangiectasia was diagnosed in 6 patients, all having
ataxia, telangiectasia, low IgA levels and elevated α feto
protein.
Of the 5 patients with chronic granulomatous disease
one was probably x linked, as 50% of the mother’s neu-
trophils gave abnormal results with the NBT test. Two
siblings had leucocyte adhesion deficiency type 1(LAD
type 1, with delayed separation of the umbilical cord,
necrotic skin ulcers with minimal pus, high neutrophil
Table 2 Spectrum of primary immune deficiency
Disease Number Sex Age
(%) M F
Combined 10 (13.6) < 1
year










Severe combined immuno deficiency
(including X linked = 02 Omenn syndrome = 01)
10 (13.6) 04 06 10 - - - - -
Well defined syndromes 10 (13.6)
Ataxia telangiectasia 06 (8.2) 02 04 - 03 03 - - -
Di George syndrome 02 (2.7) 01- 01 02 - - - - -
Hyper IgE syndrome (autosomal dominant) 02 (2.7) 01 01 - - 01 01 - -
Antibody deficient 44
(60.27)
X Linked agammaglobulinemia 15 (20.54) 15 0 01 07 05 02 - -
Autosomal recessive agammaglobulinemia 02 (2.7) 0 02 - 01 01 - -
Common variable immune deficiency 21 (28.76) 10 11 - 01 04 04 04 08
Partial IgA deficiency 01 (1.36) 0 01 - - - 01 - -
Hyper IgM syndrome (including CD 40
deficiency = 01)
05 (6.8) 03 02 - 02 03 - - -
Immune dysregulation 03 (4.1)
Griscelli syndrome 03 (4.1) 02 01 03
Phagocytic defects 06 (8.2)
Chronic granulomatous disease 04 (5.4) 04 0 01 02 01 - - -
Leucocyte adhesion deficiency type 1 02 (2.7) 0 02 02 - - - - -
Autoinflammatory 0 - - - - - - -
Innate immune defects 0 - - - - - - -
Complement defects 0 - - - - - - -
Total 73 42 31 19 16 18 08 04 08
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flowcytometry.
Three patients with Griscelli syndrome were investi-
gated for underlying immune deficiency, and were found
to have an intact immune system. Genetic identification
of a RAB 27A mutation was not attempted [28].
Three pairs of siblings had XLA, in addition to the sib-
lings with LAD.
Due to lack of diagnostic facilities, patients with auto
inflammatory, innate immune and complement defects
could not be identified.
Discussion
Seventy three patients were identified as having a primary
immune deficiency. Males were affected more than
females (1.3:1), a trend seen in other parts of the world,
including Europe [29] and India [30].It was suggested that
the higher percentage of males with primary immuno-
deficiency (PID) in India is at least partly attributed to a
bias in seeking better medical care for male children that
still exists In that society [30]. While India is Sri Lanka’sclosest neighbor, with religious and cultural affinities to
Sri Lankans, this is unlikely to be the reason for the male
preponderance in our study. However, females predo-
minated ≥18 years, and more so ≥30 years. In the
European Society of Immunodeficiency (ESID) registry,
more women than men are affected by a PID in patients
older than 30 years, the reason being unclear [29].
The majority (60.27%) had an antibody deficiency. This
is in keeping with results in Europe [29], Turkey [31], Iran
[32] Japan [33] and a center in India [34].Other centers in
India report immune dysregulation and B and T cell dis-
orders [30], and immune dysregulation and phagocytic
disorders [35] as the commonest PID. However, these
centers deal with pediatric patients. Common variable im-
mune deficiency (CVID) was the commonest PID (28.7%)
in our study, as in Europe (21.01%)[29] and Iran (20%)
[32]. CVID is less common in Japan (11%) [33], and is
under diagnosed in India [30,34,35] as the data from India
are from pediatric centers. The diagnosis of CVID has
increased from 2010 in our center due to the education
programs conducted among respiratory physicians
Table 3 Clinical features of Autosomal dominant hyper IgE syndrome, Ataxia telangiectasia, Di George syndrome
Disease Patient age and sex Clinical features
Hyper IgE syndrome 15 years, male New born rash, seborrheic dermatitis from 3 months, recurrent lower respiratory infections (> 6),
pneumonia (X3), pneumatoceles, oral thrush, recurrent skin abscesses, typical facies, nasal width,
fractures (left and right radius and ulna), Eosinophilia (> 800 / μl), IgE > 2000 IUml NIH Score 63*
9 years, female New born rash, dermatitis, recurrent skin abscesses (< 4), pneumonia (1 episode), pneumatocele,
retained primary teeth, hyperextensibility of joints, recurrent upper respiratory infections,
eosinophilia > 800 / μl, IgE > 2000 IU/ml NIH Score 41*




Alpha feto protein 111.4 ng/ml (< 8 ng/ml)
Reduced IgA
CT Brain – prominent lateral and 4th ventricle, no cerebellar atrophy
3 years, female Ataxia at 3 years, torticollis, ocular telangiectasia, sister diagnosed with ataxia telangiectasia
IgG, IgA reduced, increased IgM
1 ½ years, female Unsteady gait
Elder sister died at 11 years with ataxia telangiectasia
Ocular, ear lobe telangiectasia
Ataxia +
IgA reduced
Alpha feto protein 48.6 ng/ml (< 8 ng/ml)
8 years, male Ataxia, intention tremor
Ocular telangiectasia
Recurrent respiratory tract infection
IgA reduced
Alpha feto protein 156 ng/ml (< 8 ng/ml)
5 years, female Walking milestones delayed, ataxia after 1 ½ years, bulbar telangiectasia,
oculomotor apraxia, dyskinesia, dystonia
Immunoglobulin levels normal
Alpha feto protein 217.9 ng/ml (< 8 ng/ml)
4 ½ years, male Imbalance while walking, inability to keep posture at 1 ½ years, with progressive worsening
2 attacks of lower respiratory infection
Ocular telangiectasia. Ataxia
IgA reduced
Alpha feto protein 144.52 ng/ml (<8 ng/ml)
DiGeorge Syndrome 10 month, male Recurrent respiratory tract infection from 3 months
Hypocalcemia (no fits)
Dysmorphic facies(micrognathia,low set ears, thin upper lip, prominent philtrum,
prominent forehead, high arched palate.
Absent thymus (chest xray, ultra sound scan)
2 D Echo–normal heart
Serum immunoglobulins, lymphocyte subsets normal
3 years, female Recurrent respiratory infections, dysmorphic facies
(micrognathia, prominent philtrum, low set ears)
Hypocalcemia = serum Ca++ 1.14 mmol/l(2.15-2.55)(no fits)
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Table 3 Clinical features of Autosomal dominant hyper IgE syndrome, Ataxia telangiectasia, Di George syndrome
(Continued)
2D Echo = Tetralogy of Fallots, right sided aortic arch
Serum immunoglobulins = IgG and IgA low, IgM normal
Lymphocyte subsets and function normal
*NIH score–National Institutes of Health score [23].
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with PID are ≥ 12 years, and under the care of adult physi-
cians. IgA deficiency was seen in only one patient, and
that too a partial deficiency. IgA deficiency is the second
commonest immune deficiency in the European registry
[29] but is uncommon in Japan [33], India [30] and Iran
[32]. This may be because most patients with specific IgA
deficiency lack clinical manifestations [33].
X linked agammaglobulinemia (XLA) is the second
most common PID in our study (20.54%). These figures
are similar to Indian studies among mainly pediatric
patients, 19.1% [30], and 19.9% [34]. European figures
are much less (5.93%) [29]. It is the commonest PID in
Japan (14.7%) [33]. However, the percentage is lower as
better diagnostic techniques available enable Japan (and
European countries) to identify a larger spectrum of
PID, unlike in lower resource countries such as India
and Sri Lanka.
Of the five patients diagnosed as having hyper IgM
syndrome (HIGM), one was found to have a CD40 defi-
ciency [26], which is seen in < 1% of patients with HIGM
[27]. A genetic diagnosis is not possible at present in Sri
Lanka due to lack of flowcytometric and genetic assays.
Two of the 10 patients with severe combined immune
deficiency (SCID) had mutations in the common γ chain
and had x linked SCID. Of the 4 patients with T-B + SCID,
2 were females. While the sample size is small, X linked
SCID was present in only 20% of patients. While X linked
T –B + SCID is reported to more frequent in the rest of
the world [13,36], autosomal recessive SCID is more com-
mon in countries with increased consanguinity such as
Iran [32].
The frequency of phagocytic defects in our study is
similar to European figures, with chronic granulomatous
disease (CGD) being the commonest. Phagocytic dis-
orders are much more frequent in certain Asian coun-
tries. CGD is the second most common PID in Iran [32],
where the majority have an autosomal recessive inheri-
tance, and in Korea [36].
Complement defects were not identified as only com-
plement C3 and 4 assays were available, and terminal path
deficiencies, particularly in patients with recurrent neis-
serial infections, could not be confirmed. We could not
test for innate immune defects and auto-inflammatory
conditions. However, these are rare defects and identifiedinfrequently in the best of centers [29]. While patients
with features suggestive of periodic fevers are referred
to our unit, lack of supportive tests, including gene se-
quencing in Sri Lanka precludes confirmation of a diagno-
sis of periodic fever. This is true for innate immune
defects as well.
Tuberculosis and infections with other mycobacterial
infections are common in Sri Lanka. Patients with dis-
seminated mycobacterial (due to M.tuberculosis or non
tuberculous mycobacteria) and recurrent drug sensitive
tuberculosis in treatment compliant patients are diag-
nosed. A patient with Mendelian susceptibility to myco-
bacterial disease (IL 12 R B1 deficiency) has been reported
in Sri Lanka [37], but laboratory confirmation had to be
carried out in the UK due to lack of diagnostic facilities.
As in other less developed countries [34], there are
many challenges to be overcome in the management of
PID.
Most patients referred to our unit are from Pediatric
units. Lack of knowledge among physicians as opposed to
pediatricians, regarding primary immune deficiency is re-
sponsible for the delay in diagnosis of the many adult pa-
tients with CVID. In addition, the number of trained
Immunologists is inadequate to deal with all the patients
referred for immunological evaluation (including allergy).
Education of registrars in internal medicine and specialties
such as respiratory medicine, and General practitioners is
ongoing.
Patients with features suggestive of immunodeficiency
should be investigated. These features include [38]
severe, potentially life threatening infections, persistent
infections despite adequate treatment, recurrent infec-
tions inappropriate for age, and infections with poorly
pathogenic organisms. In addition, failure to thrive in
infancy, lymphopenia in infancy and combination of fea-
tures characteristic of immunodeficiency syndromes
(eg, ataxia telangiectasia) should indicate need for fur-
ther evaluation. A family history of immune deficiency
was a significant feature in the identification of PID in
our sample. Secondary immunodeficiencies (including
HIV/AIDS) should be excluded in all cases. As diagnos-
tic facilities are limited in our setting investigations
should be targeted according to the possible underlying
PID [14,38] (Table 4). This will minimize costs and im-
prove diagnostic services.
Table 4 Investigation of PID
PID Clinical features Suggested investigation
Combined (T and B cell deficiency) Failure to thrive, severe viral, intracellular bacterial
(atypical, extrathoracic or disseminated
tuberculosis, disseminated infections with poorly
pathogenic mycobacteria), fungal (persistent
mucocutaneous candidiasis, invasive aspergillus or
mucor), protozoal (cryptococcus meningitis,
chronic diarrhea due to giardia) infections
Interstitial pneumonitis due to P.jiroveci,
lymphopenia in infancy (< 2,500/μl)
Full blood count and differential
Lymphocyte subsets by flowcytometry (CD3,
CD 4, CD 8, CD 16 and CD 56, CD 19)
Serum immunoglobulin levels (IgG, IgA, IgM, IgE)
T cell proliferation assay
Delayed type hypersensitivity test (using purified
protein derivative, mumps, tetanus vaccines).
Further tests may be necessary
Antibody deficiency Recurrent/severe sinopulmonary infections,
arthritis, meningitis, osteomyelitis, infections with
capsulate bacteria, chronic diarrhea or
malabsorption. Viral infection
(meningoencephalitis with entero viruses)
Serum immunoglobulin levels (IgG, IgA, IgM, IgE)
Lymphocyte subsets (including CD 19). Functional
antibodies (isohemagglutinins *, anti tetanus/anti
diphtheria IgG, anti pneumococcal/anti typhoid
Vi IgG**)
Further tests may be necessary
Other well defined immune deficiencies Ataxia and telangiectasia (ataxia telangiectasia),
cardiac defects, hypocalcemia, hypoplastic thymus
and dysmorphic facial features (chromosomal
22q.11.2 deletion), eczema in infancy, recurrent
skin abscesses, pneumonia with pneumatoceles
and dysmorphic facies (hyper IgE syndrome)
Tests depend on disease
Phagocytic defects Recurrent skin abscesses or cellulitis, visceral
abscesses, mucocutaneous ulceration, granuloma
formation, invasive fungal infection,
Full blood count and differential. If neutropenia,
identify cause. If neutrophil count normal,
depending on clinical features tests for chronic
granulomatous disease (nitro blue tetrazolium
assay, dihydro rhodamine assay) or leukocyte
adhesion defect type 1 (CD18, CD 11 a, CD 11b,
CD 11c by flowcytometry) and type 2 (CD 15 by
flowcytometry)
Disseminated mycobacterial disease, BCGosis,
disseminated non typhoid salmonellosis (MSMD)
Tests in specialized laboratories
Complement defects Infections with encapsulated bacteria, recurrent
meningococcal infections, lupus like vasculitis
Functional hemolytic complement assays (CH 50
and AP 50)
If abnormal, is followed by evaluation of
individual complement components
*After one year of age.
**After 2 years of age.
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infancy. As of today, molecular and genetic diagnostic
facilities are available only for X linked SCID, XLA and
recently for chromosomal deletion 22q11.2. Only 17 pa-
tients (23.2%) had their diagnosis confirmed by genetic
assays, similar to the Indian experience (25%) [35].
Intra venous immune globulin (IVIG) is expensive and
out of reach of most patients. In addition, the prepara-
tions available are from western sources, and may not
reflect the spectrum of microbes present in an eastern
setting [34]. All patients with XLA, and patients with
CVID < 18 years are on IVIG therapy. This is provided
free of charge at government hospitals. Unfortunately,
adult patients cannot avail themselves of this facility,
and they are treated fresh frozen plasma. Patients with
chronic granulomatous disease are on co trimoxazoleand anti-fungal prophylaxis, but IFN γ therapy is not
offered.
Hematopoietic stem cell transplantation (HSCT) is not
available in Sri Lanka. Thus far, one patient, with X
linked SCID has been offered this therapy, in India, and
is 3 years old at present. Most other children with SCID
died in the first year of life. One other patient, with CD
40 deficiency underwent a HSCT in the USA.
Sri Lanka uses the oral polio vaccine (OPV), and
coverage is universal. The last case of polio was recorded
in 1991. However, patients with common variable
immune deficiency may excrete a mutated, potentially
dangerous vaccine derived polio virus (iVDPV) for long
periods, as was seen with one patient with CVID within
the present cohort. This mutated virus may pose a threat
to the community as well [39].
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up in 2000, bringing together professionals interested in
immunology, with links to international organizations
such as WAO, APAAACI and IUIS has slightly changed
the dynamics. International collaboration has made the
task of PID diagnosis slightly easier.
The present study was confined to passive case detec-
tion and the prevalence of PID in the country could not
be ascertained. However, most patients suspected of an
underlying immune deficiency are referred to this unit.
Basic investigations and a few advanced tests are carried
out, but more advanced tests are not available. Reference
values for the Sri Lankan (or even South Asian) popula-
tions are not documented. However, with these limita-
tions, the present study is one of the few studies in the
South Asian region, and the first outside India to pro-
vide an overview of PID.
Conclusion
The spectrum of PID is similar to that described in the
west, with antibody deficiency (mainly CVID and XLA)
the most common. However, IgA deficiency is uncom-
mon. Treatment of antibody deficiency has improved life
expectancy and quality of life in most patients. However,
early diagnosis of adult patients, and treatment of cellu-
lar immune deficiency is inadequate. Much needs to be
done to educate clinicians and provide better diagnostic
facilities for PID.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
NRDS–Concept and design of study, acquisition of data, analysis of data,
writing of manuscript. SG–Acquisition of data, including immunoassays.
DR–Acquisition of data, including immunoassays. GDW–Acquisition of data,
including immunoassays. All authors read and approved the final manuscript.
Authors’ information
NRDS MBBS, MD, Consultant Immunologist, SG MBBS, MD, Consultant
Immunologist. DR MBBS, Medical Officer. GDW MBBS, Medical Officer.
Acknowledgements
We acknowledge the contribution of all clinicians who referred patients, and
laboratory staff of the Department of Immunology, for the diagnostic testing.
Funding was obtained from the World Health Organization, and the Ministry
of Health, Sri Lanka.
Received: 10 August 2013 Accepted: 22 December 2013
Published: 27 December 2013
References
1. Arkwright PD, Gennery AR: Ten warning signs of primary
immunodeficiency: a new paradigm is needed for the 21st century.
Ann NY Acad Sci 2011, 1238:7–14.
2. Boyle JM, Buckley RH: Population prevalence of diagnosed primary
immunodeficiency diseases in the United States. J Clin Immunol 2007,
27:497–502.
3. Bussone G, Mouthon L: Autoimmune manifestations in primary immune
deficiencies. Autoimmun Rev 2009, 8:332–336.
4. Al-Herz W, Bousfiha A, Casanova J-L, Chapel H, Conley ME, Cunningham-Rundles C,
Etzioni A, Fischer A, Franco JL, Geha RS, Hammarström L, Nonoyama S,Notarangelo LD, Ochs HD, Puck JM, Roifman CM, Seger R, Tang MLK: Primary
immunodeficiency update on the classification from the international
union of immunological societies expert committee for primary
immunodeficiency. Front Immunol 2011, 2(54):1–26.
5. Plebani A, Soresina A, Rondelli R, Amato GM, Azzari C, Cardinale F, Cazzola G,
Consolini R, De Mattia D, Dell’Erba G, Duse M, Fiorini M, Martino S, Martire B,
Masi M, Monafo V, Moschese V, Notarangelo LD, Orlandi P, Panei P, Pession A,
Pietrogrande MC, Pignata C, Quinti I, Ragno V, Rossi P, Sciotto A, Stabile A,
Italian Pediatric Group for XLA-AIEOP: Clinical, immunological, and molecular
analysis in a large cohort of patients with x-linked agammaglobulinemia:
an Italian multicenter study. Clin Immunol 2002, 104:221–230.
6. Weiler CR, Bankers-Fulbright JL: Common variable immune deficiency:
test indications and interpretations. Mayo Clin Proc 2005, 80(9):1187–1200.
7. Kidd PG, Nicholson JKA: Immunophenotyping by flowcytometry.
In Manual of Laboratory Immunology. 5th edition. Edited by Rose NR,
De Macario EC, Folds JD, Lane HC, Nakamura RM. Washington DC:
American Society of Microbiology; 1997:229–244.
8. Check IJ, Papapadea C: Immunoglobulin quantification. In Manual of
Laboratory Immunology. 5th edition. Edited by Rose NR, de Macario EC,
Folds JD, Lane HC, Nakamura RM. Washington DC: American Society of
Microbiology; 1997:134–146.
9. Giclas P: Complement Tests. In Manual of Laboratory Immunology.
5th edition. Edited by Rose NR, de Macario EC, Folds JD, Lane HC,
Nakamura RM. Washington DC: American Society of Microbiology;
1997:181–191.
10. Mosman T: Rapid colorimetric assay for cellular growth and survival;
application to proliferation and cytotoxicity assays. J Immunol Methods
1983, 5:55–63.
11. Klein RS, Flanigan T, Schuman P, Smith D, Vlahov D, for the HER Study
Group: The effect of immunodeficiency on cutaneous delayed-type
hypersensitivity testing in HIV-infected women without anergy:
implications for tuberculin testing. Int J Tuberc Lung Dis 1999,
3(8):681–688.
12. Campbell DE, Douglas SD: Phagocytic cell function: I: oxidation and
chemotaxis. In Manual of Laboratory Immunology. 5th edition. Edited by
Rose NR, de Macario EC, Folds JD, Lane HC, Nakamura RM. Washington DC:
American Society of Microbiology; 1997:320–329.
13. Bradely LAD, Sweatman AK, Lovering RC, Jones AM, Morgan G, Levinsky RJ,
Kinnon C: Mutation detection in the X-linked agammaglobulinemia gene,
BTK, using single strand conformation polymorphism analysis. Hum Mol
Genet 1994, 3:79.
14. Rosen FS, Eibl M, Roifman C, Fischer A, France, Volanakis J, Aiuti F,
Notarangelo L, Kishimoto T, Resnick IG, Hammarstrom L, Seger R, Chapel H,
Cooper MD, Geha RS, Good RA, Waldmann TA, Wedgwood RJP: Primary
immune deficiency diseases. Report of an IUIS Scientific Committee.
Clin Exp Immunol 1999, 118(Suppl 1):1–28.
15. Baumeister FAM, Stachel D, Schuster F, Schmid I, Schaller M, Wolff H,
Weiss M, Belohradsky BH: Accelerated phase in partial albinism with
immunodeficiency (Griscelli syndrome): genetics and stem cell
transplantation in a 2-month-old girl. Eur J Pediatr 2000, 159:74–78.
16. Hanna S, Etzioni A: Leukocyte adhesion deficiencies. Ann NY Acad Sci 2012,
1250:50–55.
17. Conley ME, Notarangelo LD, Etzioni A: Diagnostic criteria for primary
immunodeficiencies: representing PAGID (Pan-American Group for
Immunodeficiency) and ESID (European Society for Immunodeficiencies).
Clin Immunol 1999, 93:190–197.
18. Yong PFK, Thaventhiran JED, Grimbacher B: “A rose is a rose is a rose”,
but CVID is not CVID: common variable immune deficiency (CVID),
What do we know in 2011? Adv Immunol 2011, III:47–107.
19. van der Burg M, Gennery AR: The expanding clinical and immunological
spectrumof severe combined immunodeficiency. Eur J Pediatr 2011,
170:561–571.
20. Mavrou A, Tsangaris GT, Roma E, Kolialexi A: The ATM gene and ataxia
telangiectasia. Anti Cancer Res 2008, 28:401–406.
21. McDonald-McGinn DM, Sullivan KE: Chromosome 22q11.2 deletion
syndrome (DiGeorge Syndrome/Velocardiofacial Syndrome). Medicine
2011, 90:1–18.
22. Sowerwine KJ, Holland SM, Freeman AF: Hyper-IgE syndrome update.
Ann NY Acad Sci 2012, 1250:25–32.
23. Grimbacher B, Schäffer AA, Holland SM, Davis J, Gallin JI, Malech HL,
Atkinson TP, Belohradsky BH, Buckley RH, Cossu F, Español T, Garty BZ,
de Silva et al. Allergy, Asthma & Clinical Immunology 2013, 9:50 Page 9 of 9
http://www.aacijournal.com/content/9/1/50Matamoros N, Myers LA, Nelson RP, Ochs HD, Renner ED, Wellinghausen N,
Puck JM: Genetic linkage of hyper-IgE syndrome to chromosome 4.
Am J Hum Genet 1999, 65:735–744.
24. Procop GW, Haddad S, Quinn J, Wilson ML, Henshaw NG, Reller LB,
Artymyshyn RL, Katanik MT, Weinstein MP: Detection of pneumocystis
jiroveci in respiratory specimens by four staining methods.
J Clin Microbiol 2004, 42(7):3333–3335.
25. Hazen KC, Howell SA: Candida, Cryptococcus and other yeasts of medical
importance. In Manual of Clinical Microbiology. 8th edition. Edited by
Murray PR, Baron EJ, Jorgenson JM, Pfaller MA, Yolker RH. Washington DC:
American Society of Microbiology Press; 2003:1693–1711.
26. Mahdavinia M, de Silva R, O’Gorman M, Fuleihan RL: Autosomal recessive
Hyper IgM (AR-HIM) due to CD40 deficiency presenting with recurrent
infections and abnormal gait. J Clin Immunol 2012, 32:38.
27. Davis EG, Thrasher AJ: Update on the hyper Immunoglobulin M
syndromes. B J Haematol 2010, 149:167–180.
28. Ménasché G, Pastural E, Feldmann J, Certain S, Ersoy F, Dupuis S, Wulffraat N,
Bianchi D, Fischer A, Le Deist F, de Saint BG: Mutations in RAB27A cause
Griscelli syndrome associated with haemophagocytic syndrome.
Nat Genet 2000, 25:173–179.
29. Gathmann B, Binder N, Eh S, Kindle G, for the ESID Registry Working Party:
The European internet-based patient and research database for primary
immunodeficiencies: update 2011. Clin Exp Immunol 2012, 167(3):479–491.
30. Chinnabhandar V, Yadav SP, Kaul D, Verma IC, Sachdeva A: Primary
immunedeficiency disorders in the developing world: data from a
hospital based registry in India. Pediatric Hematol Oncol Early Online
2013:1–5.
31. Sanal O, Tezcan I: Thirty years of primary immunodeficiencies in Turkey.
Ann NY Acad Sci 2011, 1238:15–23.
32. Razaei N, Aghamohommadi A, Moin M, Pourpak Z, Movahedi M,
Gharagozlou M, Atarod L, Ghazi BM, Isaeian A, Mahmoudi M, Abolmaali K,
Mansouri D, Arshi S, Tarash NJ, Sherkat R, Akbari H, Amin R, Alborzi A,
Kashef S, Farid R, Mohammadzadeh I, Shabestari MS, Nabavi M, Farhoudi A:
Frequency and clinical manifestations of patients with primary
immunodeficiency disorders in Iran: update from the Iranian primary
immunodeficiency registry. J Clin Immunol 2006, 26(6):519–532.
33. Takada H: Primary immunodeficiency in Japan; epidemiology, diagnosis
and pathogenesis. Pediatr Int 2013. doi:10.1111/ped.12224.
34. Gupta S, Madkaikar M, Singh S, Sehgal S: Primary immunodeficiencies in
India: a perspective. Ann NY Acad Sci 2012, 1250:73–79.
35. Madkaikar M, Mishra A, Desai M, Gupta M, Mhatre S, Ghosh K:
Comprehensive report of primary immunodeficiency disorders from a
tertiary care center in India. J Clin Immunol 2013, 33(3):507–512.
36. Rhim JW, Kim QH, Kim DS, Kim BS, Kim JS, Kim CH, Kim HM, Park HJ, Pai KS,
Son BK, Shin KS, Oh MY, Woo YJ, Yoo Y, Lee KSI, Lee KY, Lee CG, Lee JS,
Chung EH, Choi EH, Hahn YS, Hyun Young P, Kim JG: Prevalence of
primary immunodeficiency in Korea. J Korean Med Sci 2012, 27:788–793.
37. Senanayake MP, Doffinger R, Kumararatne DS: Recurrent and unusual
manifestations of tuberculosis in a boy with interleukin 12 receptor
defect. Cey Med J 2009, 54(2):54–55.
38. Kumararatne D: Immunodeficiency. In Oxford Textbook of Medicine.
5th edition. Edited by Warrell DA, Cox TM, Firth JD. Oxford:
Oxford University Press; 2010:1–53.
39. de Silva R, Gunasena S, Ratnayake D, Wickremesinghe GD, Kumarasiri CD,
Pushpakumara BA, Deshpande J, Kahn AL, Sutter RW: Prevalence of
prolonged and chronic poliovirus excretion among persons with primary
immune deficiency disorders in Sri Lanka. Vaccine 2012, 30(52):7561–7565.
doi:10.1186/1710-1492-9-50
Cite this article as: de Silva et al.: Spectrum of primary
immunodeficiency disorders in Sri Lanka. Allergy, Asthma & Clinical
Immunology 2013 9:50.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
